Recent progress in cancer care continue to offer optimism for patients. Researchers are diligently exploring novel approaches, including immunotherapy , targeted treatments , and precision approaches. A key finding published this week showcases the potential of a experimental drug in managing late-stage NSCLC. Furthermore, current trials are focusi